Blarcamesine Shows Promising Results in Phase 2 Extension Study Led by Anavex Life Sciences

Anavex Life Sciences, or Anavex, a leading biopharmaceutical company, has recently announced positive findings from the 48-week, open-label extension of their phase 2 study involving blarcamesine. This investigational agent has shown significant potential in the treatment of Parkinson’s disease dementia (PDD).  Despite the challenges posed by the COVID-19 pandemic, the extension study demonstrated that patients […]

Continue reading

Margarita Howard: Pioneering Success in Government Contracting

Margarita Howard, the founder and CEO of HX5, has established herself as a trailblazer in the competitive world of government contracting. With Margarita Howard’s strategic vision and unwavering determination, Howard has led HX5 to become a leading provider of professional mission support services to federal space and defense agencies.  Howard’s journey in the industry began […]

Continue reading